A commentary on 'Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023'
- PMID: 37851496
- PMCID: PMC10583953
- DOI: 10.1097/JS9.0000000000000576
A commentary on 'Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023'
Conflict of interest statement
There are no conflicts of interest in our commentary.
Comment on
-
Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023.Int J Surg. 2023 Apr 1;109(4):658-659. doi: 10.1097/JS9.0000000000000258. Int J Surg. 2023. PMID: 36912521 Free PMC article. No abstract available.
References
-
- Yildirim M, Solmaz F. COVID-19 burnout, COVID-19 stress and resilience: initial psychometric properties of COVID-19 Burnout Scale. Death Stud 2022;46:524–532. - PubMed
-
- Budd J, Miller BS, Manning EM, et al. . Digital technologies in the public-health response to COVID-19. Nat Med 2020;26:1183–1192. - PubMed
-
- Saavedra J, Faviero GF, Kurtovic A, et al. . Funding pandemic prevention, preparedness, and response through partnership models. Lancet Public Health 2023;8:e13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous